BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26385505)

  • 21. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.
    Naito R; Miyauchi K; Ogita M; Kasai T; Kawaguchi Y; Tsuboi S; Konishi H; Okazaki S; Kurata T; Daida H
    J Cardiol; 2014 Feb; 63(2):106-11. PubMed ID: 24011926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.
    Arbel Y; Zlotnik M; Halkin A; Havakuk O; Berliner S; Herz I; Rabinovich I; Keren G; Bazan S; Finkelstein A; Banai S
    Clin Res Cardiol; 2014 Mar; 103(3):223-7. PubMed ID: 24271460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study.
    Che Q; Zhang Y; Wang J; Wan Z; Fu X; Chen J; Yan H; Chen Y; Ge J; Chen D; Huo Y
    J Diabetes Investig; 2020 Nov; 11(6):1498-1506. PubMed ID: 32383543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
    Zhang KP; Guo QC; Mu N; Liu CH
    Medicine (Baltimore); 2024 Jun; 103(24):e38563. PubMed ID: 38875361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of admission red cell distribution width on long-term cardiovascular events after primary percutaneous intervention: A four-year prospective study.
    Isik T; Kurt M; Tanboga IH; Ayhan E; Gunaydin ZY; Kaya A; Uyarel H
    Cardiol J; 2016; 23(3):281-8. PubMed ID: 26711461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Hemoglobin A1c and Major Adverse Coronary Events in Patients with Diabetes Following Coronary Artery Bypass Surgery.
    Turgeon RD; Koshman SL; Youngson E; Pearson GJ
    Pharmacotherapy; 2020 Feb; 40(2):116-124. PubMed ID: 31883378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosylated hemoglobin and outcomes in diabetic patients with acute myocardial infarction after successful revascularization with stent placement: findings from the guthrie health off-label stent (GHOST) investigators.
    Singla A; Orshaw P; Boura J; Harjai KJ
    J Interv Cardiol; 2012 Jun; 25(3):262-9. PubMed ID: 22376172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients.
    Corrada E; Cappelleri A; Belli G; Genovese S; Barbaro C; Gasparini G; Pagnotta P; Rossi M; Zavalloni D; Presbitero P
    Minerva Cardioangiol; 2008 Oct; 56(5):445-52. PubMed ID: 18813179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemoglobin A
    She J; Deng Y; Wu Y; Xia Y; Li H; Liang X; Shi R; Yuan Z
    Cardiovasc Diabetol; 2017 Aug; 16(1):97. PubMed ID: 28789650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of neutrophil gelatinase-associated lipocalin and glycosylated hemoglobin for non-ST-segment elevation myocardial infarction patients with single concomitant chronic total occlusion following primary percutaneous coronary intervention: A prospective observational study.
    Peng W; Zhang C; Wang Z; Yang W; Luo H; Li X; Fu D; Yu C; Zhou Y
    Medicine (Baltimore); 2019 Sep; 98(39):e16982. PubMed ID: 31574797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
    Cicek G; Uyarel H; Ergelen M; Ayhan E; Abanonu GB; Eren M; Gibson CM
    Coron Artery Dis; 2011 May; 22(3):131-7. PubMed ID: 21394027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of the hemoglobin A1c level in non-diabetic patients undergoing percutaneous coronary intervention: a meta-analysis.
    Li Y; Li XW; Zhang YH; Zhang LM; Wu QQ; Bai ZR; Si J; Zuo XB; Shi N; Li J; Chu X
    Chin Med J (Engl); 2020 Sep; 133(18):2229-2235. PubMed ID: 32826614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
    Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
    Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of Glycated Hemoglobin for Assessment of Glucose Metabolism in Patients With ST-Segment Elevation Myocardial Infarction.
    Aggarwal B; Shah GK; Randhawa M; Ellis SG; Lincoff AM; Menon V
    Am J Cardiol; 2016 Mar; 117(5):749-53. PubMed ID: 26768673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
    Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
    Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis.
    Schillinger M; Exner M; Amighi J; Mlekusch W; Sabeti S; Rumpold H; Wagner O; Minar E
    Circulation; 2003 Nov; 108(19):2323-8. PubMed ID: 14557362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-sensitivity C-reactive protein as a predictor of cardiovascular events after ST-elevation myocardial infarction.
    Ribeiro DR; Ramos AM; Vieira PL; Menti E; Bordin OL; Souza PA; Quadros AS; Portal VL
    Arq Bras Cardiol; 2014 Jul; 103(1):69-75. PubMed ID: 25120085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients.
    Knudsen EC; Seljeflot I; Abdelnoor M; Eritsland J; Mangschau A; Arnesen H; Andersen GO
    Cardiovasc Diabetol; 2009 Jan; 8():6. PubMed ID: 19183453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.